| Neutralization of tumor acidity improves antitumor responses to immunotherapy S Pilon-Thomas, KN Kodumudi, AE El-Kenawi, S Russell, AM Weber, ... Cancer research 76 (6), 1381-1390, 2016 | 554 | 2016 |
| Spatial heterogeneity and evolutionary dynamics modulate time to recurrence in continuous and adaptive cancer therapies JA Gallaher, PM Enriquez-Navas, KA Luddy, RA Gatenby, ARA Anderson Cancer research 78 (8), 2127-2139, 2018 | 217 | 2018 |
| Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer A El-Kenawi, C Gatenbee, M Robertson-Tessi, R Bravo, J Dhillon, ... British journal of cancer 121 (7), 556-566, 2019 | 117 | 2019 |
| Abscopal benefits of localized radiotherapy depend on activated T-cell trafficking and distribution between metastatic lesions JT Poleszczuk, KA Luddy, S Prokopiou, M Robertson-Tessi, EG Moros, ... Cancer research 76 (5), 1009-1018, 2016 | 116 | 2016 |
| T-cells produce acidic niches in lymph nodes to suppress their own effector functions H Wu, V Estrella, M Beatty, D Abrahams, A El-Kenawi, S Russell, ... Nature communications 11 (1), 4113, 2020 | 102 | 2020 |
| Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth M Mediavilla-Varela, K Luddy, D Noyes, FK Khalil, AM Neuger, H Soliman, ... Cancer biology & therapy 14 (9), 860-868, 2013 | 101 | 2013 |
| Hepatic tumor microenvironments and effects on NK cell phenotype and function J Piñeiro Fernández, KA Luddy, C Harmon, C O’Farrelly International journal of molecular sciences 20 (17), 4131, 2019 | 96 | 2019 |
| Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival J Poleszczuk, K Luddy, L Chen, JK Lee, LB Harrison, BJ Czerniecki, ... Breast cancer research 19, 1-7, 2017 | 88 | 2017 |
| Tris–base buffer: a promising new inhibitor for cancer progression and metastasis A Ibrahim‐Hashim, D Abrahams, PM Enriquez‐Navas, K Luddy, ... Cancer medicine 6 (7), 1720-1729, 2017 | 53 | 2017 |
| The effects of anesthetics and perioperative medications on immune function: a narrative review RS Ackerman, KA Luddy, BE Icard, JP Fernández, RA Gatenby, ... Anesthesia & Analgesia 133 (3), 676-689, 2021 | 49 | 2021 |
| The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition KA Luddy, M Robertson-Tessi, NK Tafreshi, H Soliman, DL Morse Frontiers in immunology 5, 97285, 2014 | 48 | 2014 |
| The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition KA Luddy, M Robertson-Tessi, NK Tafreshi, H Soliman, DL Morse Frontiers in immunology 5, 97285, 2014 | 48 | 2014 |
| Paclitaxel and TRAIL synergize to kill paclitaxel-resistant small cell lung cancer cells through a caspase-independent mechanism mediated through AIF TB Hunter, NJ Manimala, KA Luddy, T Catlin, SJ Antonia Anticancer research 31 (10), 3193-3204, 2011 | 44 | 2011 |
| The goldilocks window of personalized chemotherapy: getting the immune response just right DS Park, M Robertson-Tessi, KA Luddy, PK Maini, MB Bonsall, ... Cancer research 79 (20), 5302-5315, 2019 | 39 | 2019 |
| The immune checkpoint kick start: Optimization of neoadjuvant combination therapy using game theory J West, M Robertson-Tessi, K Luddy, DS Park, DFK Williamson, ... JCO clinical cancer informatics 3, 1-12, 2019 | 30 | 2019 |
| Predator-prey in tumor-immune interactions: A wrong model or just an incomplete one? I Kareva, KA Luddy, C O’Farrelly, RA Gatenby, JS Brown Frontiers in Immunology 12, 668221, 2021 | 18 | 2021 |
| Searching for Goldilocks: How evolution and ecology can help uncover more effective patient-specific chemotherapies DS Park, KA Luddy, M Robertson-Tessi, C O'Farrelly, RA Gatenby, ... Cancer Research 80 (23), 5147-5154, 2020 | 12 | 2020 |
| Extracellular acidosis alters polarization of macrophages AE El-Kenawi, AA Ibrahim-Hashim, KA Luddy, SA Pilon-Thomas, ... Cancer Research 75 (15_Supplement), 3213-3213, 2015 | 10 | 2015 |
| Transforming growth factor β signaling overcomes dasatinib resistance in lung cancer E Gordian, J Li, Y Pevzner, M Mediavilla-Varela, K Luddy, K Ohaegbulam, ... PLoS One 9 (12), e114131, 2014 | 10 | 2014 |
| Adaptive vs continuous cancer therapy: Exploiting space and trade-offs in drug scheduling JA Gallaher, PM Enriquez-Navas, KA Luddy, RA Gatenby, AR Anderson bioRxiv 3, 128959, 2017 | 7 | 2017 |
Robert GilliesChair of Cancer Physiology, H. Lee Moffitt Cancer CenterVerifierad e-postadress på moffitt.org
